As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Clinical Trials Arena on MSN
The Bayesian challenge: complexity that pays off
The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
Suggested Citation: "Appendix D: Using Bayes Analysis for Hypothesis Testing." National Academies of Sciences, Engineering, and Medicine. 2019. Reproducibility and ...
We consider the usual proportional hazards model in the case where the baseline hazard, the covariate link, and the covariate coefficients are all unknown. Both the baseline hazard and the covariate ...
Journal of the Royal Statistical Society. Series A (Statistics in Society), Vol. 180, No. 4 (OCTOBER 2017), pp. 1191-1209 (19 pages) Area level models, such as the Fay–Herriot model, aim to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results